RUNX2, RUNX family transcription factor 2, 860

N. diseases: 405; N. variants: 37
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE Taken together, our results show that circulating miR-19b plays an important role in enhancing osteoblastogenesis, possibly through regulation of the PTEN/pAKT/Runx2 pathway, and may be a useful therapeutic target in bone loss disorders, such as osteoporosis. 31614022 2020
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 AlteredExpression disease BEFREE The probable positive effects of photobiomodulation therapy (PBMT) and oxytocin (OT) treatments together or alone were evaluated on cell viability along with the changes in the gene expression of Osteocalcin (OC), Osteoprotegerin (OPG), and Runt-related transcription factor 2 (Runx2) levels of sham (healthy)-Bone marrow mesenchymal stem cell(BMMSC) and ovariectomy-induced osteoporosis (OVX)-BMMSC. 31399862 2020
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 AlteredExpression disease BEFREE Overexpression of GAS5 promotes osteogenic differentiation of hMSCs through regulating microRNA-498 to up-regulate RUNX2 expression, thus alleviating the development of osteoporosis. 31599401 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE There were abnormal changes in the protein expressions of Bmp-2, Smad1, Smad5 and Runx2 in bone tissue, which may be an important mechanism underlying the development of kidney deficiency osteoporosis. 31304902 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 AlteredExpression disease BEFREE All of the above indicate that oral administration of icariin can prevent diabetic osteoporosis; the effect is mainly related to its ability to reduce blood glucose, inhibit bone turnover and bone marrow adipogenesis, as well as up-regulate bone RUNX 2, and OPG expression. 31096652 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE Taken together, these results suggest that miR-135a-5p may serve a role in osteoporosis progression by regulating osteogenic differentiation via RUNX2. 31555350 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 GeneticVariation disease BEFREE OP patients presented a higher serum level of miRNA-217 and lower serum levels of circ-VANGL1 and RUNX2 relative to non-OP patients. 30779060 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE Chromatin immunoprecipitation showed that higher methylation was associated with reduced SP7, RUNX2, and ERα binding to the <i>SOST</i> promoter in patients with osteoporosis. 30257098 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE LncRNA XIXT upregulated RUNX2 by absorbing miRNA-30a-5p, and thus induced hBMSCs osteogenesis to alleviate osteoporosis. 31696458 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE MiRNA-365a-3p negatively regulates osteogenic differentiation of hBMSCs by targeting RUNX2, thus promoting the progression of osteoporosis. 31599402 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 GeneticVariation disease BEFREE Cleidocranial dysplasia (CCD) in humans is an autosomal-dominant skeletal dysplasia caused by heterozygous mutations of the runt-related transcription factor 2 (RUNX2) and significantly increases the risk of osteoporosis. 30506733 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE The present results suggested that miR‑488 is a negative regulator of psoralen‑induced BMSC osteogenic differentiation by targeting Runx2, providing a possible therapeutic target for osteoporosis. 31485621 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE However, MSC-based therapy for osteoporosis in CCD patients is difficult due to a reduction in the ability of MSCs to differentiate into osteoblasts resulting from impaired RUNX2 function. 29357927 2018
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 AlteredExpression disease BEFREE Moreover, caudal vein injection of agomir-23b notably caused severe osteoporosis in mice, and forced expression of runx2 by combined injecting Ad-runx2 attenuated the bone loss induced by miR-23b. 29234953 2018
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE CircRUNX2 through has-miR-203 regulates RUNX2 to prevent osteoporosis. 30324718 2018
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE Plausibly, homeostatic feedback loops that rely on Runx2 activation to compensate for bone loss in GIO are thwarted, exacerbating disease progression through stimulation of Wif1.. 27061521 2017
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 AlteredExpression disease BEFREE Taken together, these data implied that miR-221 played an important part in osteoporosis through regulating RUNX2 expression and osteoblast differentiation. 28123639 2017
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 GeneticVariation disease BEFREE Four of these candidate variants (one each in CXXC1 and RUNX2 and two in LRP5) had a >70% derived allele frequency in East Asians, but were present at lower (20-60%) frequency in Europeans as well, suggesting that the adaptation might have been part of a common response to climatic and dietary changes as humans expanded out of Africa, with implications for their role in vitamin D-dependent bone mineralization and osteoporosis insurgence. 26719974 2015
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE Regulation of bone formation by RUNX2 and PPARγ2 is modified in OA compared to OP, resulting in higher osteoblastogenesis and adipogenesis in OA. 21854818 2011
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE Oxidative stress is implicated in osteoporosis; furthermore the osteoblast transcriptional factor RUNX2 is reported to play a protective role against osteoporosis in postmenopausal women. 19017541 2009
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE Thus, RUNX2 is a good candidate for the genetic determination of osteoporosis. 17878995 2007
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 Biomarker disease BEFREE Cbfa-1 (Runx-2) and osteocalcin expression by human osteoblasts in heparin osteoporosis in vitro. 17000892 2006
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 GeneticVariation disease BEFREE The A allele was associated with increased BMD and was protective against a common form of osteoporotic fracture, suggesting that RUNX2 variants may be related to genetic effects on BMD and osteoporosis. 12162506 2002
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 AlteredExpression disease BEFREE These data indicate that Runx2 expression in osteoblasts is reduced by hypoxia, and may be a mechanism of osteoporosis by decreased vascular supply. 12088880 2002
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.200 AlteredExpression disease LHGDN These data indicate that Runx2 expression in osteoblasts is reduced by hypoxia, and may be a mechanism of osteoporosis by decreased vascular supply. 12088880 2002